{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:57:41Z","timestamp":1792519061205,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Total pelvic exenteration (PE) is a surgical resection of all pelvic organs used as a palliative treatment for locally advanced or recurrent pelvic malignancies. This case report describes an entero-vascular fistula as a severe complication following radiotherapy in a patient with recurrent cervical cancer who underwent PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present the case of a 47-year-old woman who was diagnosed with cervical cancer at the age of 43 years, classified as FIGO stage IIB. She underwent a radical hysterectomy followed by concurrent chemoradiotherapy (CCRT). In 2023, she developed a recto-urethral fistula and subsequently underwent PE. In March 2024, she was admitted for right buttock and leg pain. An evaluation revealed bone metastasis in the lumbar vertebrae, left iliac bone, and sacrum, for which local radiotherapy was administered. Later, she complained of bloody discharge from a sacral fistula and upper abdominal pain. Her blood pressure was 105\/65 mmHg, heart rate 75 beats per minute (BPM), and hemoglobin level was 7.8\u00a0g\/dL, prompting an emergency blood transfusion. Abdomino-pelvic computed tomography (APCT) scan and esophagogastroduodenoscopy (EGD) revealed a large amount of bloody fluid in the stomach and suggested communication with the bowel loop. CT angiography showed contrast extravasation from the left external iliac artery and a large hematoma. A stent graft was inserted at the site of the entero-vascular fistula to achieve embolization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights an entero-vascular fistula as one of the severe complications following PE and radiotherapy for recurrent cervical cancer. Patients who have undergone multimodal treatment, including PE, may have a pelvic condition that is more vulnerable to radiation. Therefore, the complications that may arise from radiation therapy, such as fistula formation, could be higher compared to patients who have not undergone PE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-025-03840-x","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:44:04Z","timestamp":1752137044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Entero-vascular fistula following radiotherapy in a patient with recurrent cervical cancer post-pelvic exenteration: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"In Sun","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Young","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"5","key":"3840_CR1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1245\/ASO.2006.03.082","volume":"13","author":"TM Pawlik","year":"2006","unstructured":"Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2006;13(5):612\u201323.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3840_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0090-8258(89)90047-4","volume":"35","author":"AP Anthopoulos","year":"1989","unstructured":"Anthopoulos AP, Manetta A, Larson JE, Podczaski ES, Bartholomew MJ, Mortel R. Pelvic exenteration: a morbidity and mortality analysis of a seven-year experience. Gynecol Oncol. 1989;35(2):219\u201323.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"3840_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00000658-194904000-00008","volume":"129","author":"A Brunschwig","year":"1949","unstructured":"Brunschwig A. Complete excision of pelvic viscera in the male for advanced carcinoma of the sigmoid invading the urinary bladder. Ann Surg. 1949;129(4):499\u2013504.","journal-title":"Ann Surg"},{"issue":"5","key":"3840_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/SLA.0000000000003533","volume":"270","author":"PELVEX Collaborative","year":"2019","unstructured":"PELVEX Collaborative. Pelvic exenteration for advanced nonrectal pelvic malignancy. Ann Surg. 2019;270(5):899\u2013905.","journal-title":"Ann Surg"},{"issue":"2","key":"3840_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/SLA.0000000000001524","volume":"264","author":"CA Harris","year":"2016","unstructured":"Harris CA, Solomon MJ, Heriot AG, Sagar PM, Tekkis PP, Dixon L, et al. The outcomes and patterns of treatment failure after surgery for locally recurrent rectal Cancer. Ann Surg. 2016;264(2):323\u20139.","journal-title":"Ann Surg"},{"issue":"2","key":"3840_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1245\/s10434-019-07816-8","volume":"27","author":"O Peacock","year":"2020","unstructured":"Peacock O, Waters PS, Kong JC, Warrier SK, Wakeman C, Eglinton T, et al. Complications after extended radical resections for locally advanced and recurrent pelvic malignancies: A 25-Year experience. Ann Surg Oncol. 2020;27(2):409\u201314.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3840_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ygyno.2018.10.036","volume":"152","author":"L Tortorella","year":"2019","unstructured":"Tortorella L, Casarin J, Mara KC, Weaver AL, Multinu F, Glaser GE, et al. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol. 2019;152(1):151\u20136.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3840_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/bjs.9392","volume":"101","author":"JM Young","year":"2014","unstructured":"Young JM, Badgery-Parker T, Masya LM, King M, Koh C, Lynch AC, et al. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg. 2014;101(3):277\u201387.","journal-title":"Br J Surg"},{"issue":"2","key":"3840_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ygyno.2012.09.030","volume":"128","author":"YA Rezk","year":"2013","unstructured":"Rezk YA, Hurley KE, Carter J, Dao F, Bochner BH, Aubey JJ, et al. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol. 2013;128(2):191\u20137.","journal-title":"Gynecol Oncol"},{"issue":"20","key":"3840_CR10","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","volume":"385","author":"N Colombo","year":"2024","unstructured":"Colombo N, Dubot C, Lorusso D, et al. Pembrolizumab for persistent, recurrent, or metastatic cervical Cancer. N Engl J Med. 2024;385(20):1856\u201367.","journal-title":"N Engl J Med"},{"issue":"8","key":"3840_CR11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJMoa1309748","volume":"370","author":"KS Tewari","year":"2014","unstructured":"Tewari KS, Sill MW, Long HJ 3rd, et al. Improved survival with bevacizumab in advanced cervical Cancer. N Engl J Med. 2014;370(8):734\u201343.","journal-title":"N Engl J Med"},{"issue":"10460","key":"3840_CR12","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","volume":"404","author":"D Lorusso","year":"2024","unstructured":"Lorusso D, Xiang Y, Hasegawa K, et al. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18):overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2024;404(10460):1321\u201332.","journal-title":"Lancet"},{"issue":"4","key":"3840_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/cancers16040817","volume":"16","author":"ACF Ubinha","year":"2024","unstructured":"Ubinha ACF, Pedr\u00e3o PG, Tadini AC, Schmidt RL, Santos MHD, Andrade CEMDC, et al. The role of pelvic exenteration in cervical cancer: A review of the literature. Cancers (Basel). 2024;16(4):817.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"3840_CR14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10151-018-1883-1","volume":"22","author":"E Platt","year":"2018","unstructured":"Platt E, Dovell G, Smolarek S. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer. Tech Coloproctol. 2018;22(11):835\u201345.","journal-title":"Tech Coloproctol"},{"issue":"10","key":"3840_CR15","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/bjs.11203","volume":"106","author":"RL Venchiarutti","year":"2019","unstructured":"Venchiarutti RL, Solomon MJ, Koh CE, Young JM, Steffens D. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity. Br J Surg. 2019;106(10):1393\u2013403.","journal-title":"Br J Surg"},{"issue":"11","key":"3840_CR16","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.ejso.2021.12.470","volume":"48","author":"P Persson","year":"2022","unstructured":"Persson P, Chong P, Steele CW, Quinn M. Prevention and management of complications in pelvic exenteration. Eur J Surg Oncol. 2022;48(11):2277\u201383.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3840_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12893-021-01272-6","volume":"21","author":"S Granieri","year":"2021","unstructured":"Granieri S, Sessa F, Bonomi A, Paleino S, Bruno F, Chierici A, et al. Indications and outcomes of enterovesical and colovesical fistulas: systematic review of the literature and meta-analysis of prevalence. BMC Surg. 2021;21(1):265.","journal-title":"BMC Surg"},{"key":"3840_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ygyno.2023.02.010","volume":"171","author":"LR Moolenaar","year":"2023","unstructured":"Moolenaar LR, van Rangelrooij LE, van Poelgeest MIE, van Beurden M, van Driel WJ, van Lonkhuijzen LRCW, et al. Clinical outcomes of pelvic exenteration for gynecologic malignancies. Gynecol Oncol. 2023;171:114\u201320.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3840_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12885-024-11836-3","volume":"24","author":"JH Yu","year":"2024","unstructured":"Yu JH, Tong CJ, Huang QD, Ye YL, Chen G, Li H, et al. Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study. BMC Cancer. 2024;24(1):88.","journal-title":"BMC Cancer"},{"key":"3840_CR20","doi-asserted-by":"publisher","first-page":"101702","DOI":"10.1016\/j.suronc.2021.101702","volume":"40","author":"D Haidopoulos","year":"2022","unstructured":"Haidopoulos D, Pergialiotis V, Aggelou K, Thomakos N, Alexakis N, Stamatakis E, et al. Pelvic exenteration for gynecologic malignancies: the experience of a tertiary center from Greece. Surg Oncol. 2022;40:101702.","journal-title":"Surg Oncol"},{"issue":"4","key":"3840_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3802\/jgo.2012.23.4.242","volume":"23","author":"HJ Yoo","year":"2012","unstructured":"Yoo HJ, Lim MC, Seo SS, Kang S, Yoo CW, Kim JY, et al. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer center in Korea. J Gynecol Oncol. 2012;23(4):242\u201350.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"3840_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","volume":"125","author":"A-M Schmidt","year":"2012","unstructured":"Schmidt A-M, Imesch P, Fink D, Egger H. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol. 2012;125(3):604\u20139.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"3840_CR23","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1111\/ans.17734","volume":"92","author":"RJ Shine","year":"2022","unstructured":"Shine RJ, Glyn T, Frizelle F. Pelvic exenteration: a review of current issues\/controversies. ANZ J Surg. 2022;92(11):2822\u20138.","journal-title":"ANZ J Surg"},{"issue":"1","key":"3840_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.suronc.2012.11.001","volume":"22","author":"R Mirnezami","year":"2013","unstructured":"Mirnezami R, Chang GJ, Das P, Chandrakumaran K, Tekkis P, Darzi A, et al. Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications. Surg Oncol. 2013;22(1):22\u201335.","journal-title":"Surg Oncol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03840-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:49:11Z","timestamp":1757209751000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3840"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03840-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5800557\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of our institution on November 8, 2024 (KC24ZASI0726).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient and\/or her legal guardians for their participation in this study. Additionally, written consent was secured from the individual and\/or their legal guardians for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}